PD
ABBV icon

Planning Directions’s AbbVie ABBV Stock Holding History

Planning Directions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,730
Closed -$271K – 53
2019
Q2 		$271K Buy
3,730
+130
+4% +$10.2K 0.28% 47
2019
Q1 		$290K Sell
3,600
-290
-7% -$23.7K 0.34% 42
2018
Q4 		$359K Buy
3,890
+126
+3% +$11.1K 0.44% 38
2018
Q3 		$356K Buy
3,764
+271
+8% +$25.7K 0.33% 37
2018
Q2 		$324K Buy
3,493
+367
+12% +$35.8K 0.31% 40
2018
Q1 		$296K Buy
+3,126
New +$343K 0.29% 44

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Planning Directions's ABBV Position: Q3 2019 in Review

Planning Directions sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 3,730 shares — an estimated $271K sold.

Planning Directions first reported a position in ABBV in Q1 2018 and held it in 6 quarters. The position peaked at $359K in Q4 2018. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Planning Directions reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Planning Directions sold 3,730 AbbVie shares in Q3 2019, an estimated $271K.
  • Planning Directions first reported a position in AbbVie in Q1 2018 and held it in 6 quarters.
  • Planning Directions's AbbVie position peaked at $359K in Q4 2018.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Planning Directions's 13F filing for Q3 2019, filed 25 Oct 2019.